The benefits of not using exogenous substances to prepare substrates for hyperpolarized MRI

Imaging in Medicine

Volumn 6, Issue 1, 2014, Pages 1-3

  Comment, Arnaud ^a  

^a EPFL   (Switzerland)

Author keywords

carbon 13; dynamic nuclear polarization; hyperpolarization; metabolism; molecular imaging; MRI; nuclear magnetic resonance; photo induced; radicals; UV

Indexed keywords

CARBON 13; FREE RADICAL; GADOLINIUM; HELIUM; PYRUVIC ACID;

CARBON NUCLEAR MAGNETIC RESONANCE; CLINICAL TRIAL (TOPIC); HUMAN; HYPERPOLARIZATION; MAGNETIC FIELD; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; RISK REDUCTION; SIGNAL NOISE RATIO;

EID: 84896796929     PISSN: 17555191     EISSN: 17555205     Source Type: Journal    
DOI: 10.2217/iim.13.75     Document Type: Review

References (18)

1. Kaelin WG, Thompson CB. CANCER clues from cell metabolism. Nature 465, 562-564 (2010).
2. Neubauer S. Mechanisms of disease-the failing heart. An engine out of fuel. N. Engl. J. Med. 356, 1140-1151 (2007).
3. Taegtmeyer H. Metabolism-the lost child of cardiology. J. Am. Coll. Cardiol. 36, 1386-1388 (2000).
4. Lopaschuk GD, Ussher JR, Folmes CDL, Jaswal JS, Stanley WC. Myocardial fatty acid metabolism in health and disease. Physiol. Rev. 90, 207-258 (2010).
5. Vander Heiden MG. Targeting cancer metabolism: a therapeutic window opens. Nat. Rev. Drug Discov. 10, 671-684 (2011).
6. Ardenkjaer-Larsen JH, Fridlund B, Gram A et al. Increase in signal-to-noise ratio of <10, 000 times in liquisd-state NMR. Proc. Natl Acad. Sci. USA 100, 10158-10163 (2003).
7. Golman K, Petersson JS. Metabolic imaging and other applications of hyperpolarized C-13. Acad. Radiol. 13, 932-942 (2006).
8. Golman K, In't Zandt R, Thaning M. Real-time metabolic imaging. Proc. Natl Acad. Sci. USA 103, 11270-11275 (2006).
9. Kurhanewicz J, Vigneron DB, Brindle K et al. Analysis of cancer metabolism by imaging hyperpolarized nuclei: prospects for translation to clinical research. Neoplasia 13, 81-97 (2011).
10. 13C MRI assist clinical decision-making for patients with heart disease? NMR Biomed. 24, 973-979 (2011).
11. Rider OJ, Tyler DJ. Clinical implications of cardiac hyperpolarized magnetic resonance imaging. J. Cardiovasc. Magn. Reson. 15, 93 (2013).
12. 1-13C-pyruvate. Sci. Transl. Med. 5, 198ra108 (2013).
13. Eichhorn TR, Takado Y, Salameh N et al. Hyperpolarization without persistent radicals for in vivo real-time metabolic imaging. Proc. Natl Acad. Sci. USA 110, 18064-18069 (2013).
14. Ardenkjaer-Larsen JH, Leach AM, Clarke N, Urbahn J, Anderson D, Skloss TW. Dynamic nuclear polarization polarizer for sterile use intent. NMR Biomed. 24, 927-32 (2011).
15. Golman K, Ardenkjaer-Larsen JH, Svensson J et al. C-13-angiography. Acad. Radiol. 9, S507-S510 (2002).
16. Ledneva E, Karie S, Launay-Vacher V, Janus N, Deray G. Renal safety of gadolinium-based contrast media in patients with chronic renal insuffciency. Radiology 250, 618-628 (2009).
17. Pruessmann KP. Medical imaging-less is more. Nature 455, 43-44 (2008).
18. Nuttall WJ, Clarke RH, Glowacki BA. Resources: stop squandering helium. Nature 485, 573-575 (2012).